PharmaVentures Ltd Press Releases - PRWeb Press Release Group http://www.rsspad.com/rss2/43214.xml PharmaVentures Ltd Press Releases - Powered by PRWeb and RSSPad en xml@emediawire.com xml@emediawire.com 30 Roche:Genentech Integration Latest: Exclusive Interview on PharmaTelevision http://www.prweb.com/releases/pharmatelevision/roche/prweb2499074.htm PharmaTelevision, announced today the broadcast of its exclusive interview with Roche and Genentech on the Roche:Genentech integration. (PRWeb Jun 4, 2009)

Read the full story at http://www.prweb.com/releases/pharmatelevision/roche/prweb2499074.htm

]]> Thu, 04 Jun 2009 07:00:00 GMThttp://www.prweb.com/releases/pharmatelevision/roche/prweb2499074.htm Pfizer - Wyeth: Good Deal – Bad Deal? http://www.prweb.com/releases/2009/01/prweb1905804.htm If Pfizer and Wyeth merge to create a $60 billion company, will it be a good deal or a bad deal? Fintan Walton, PhD, CEO of PharmaVentures, says, ‘This is potentially a bad deal for both companies. (PRWeb Jan 23, 2009)

Read the full story at http://www.prweb.com/releases/2009/01/prweb1905804.htm

]]> Fri, 23 Jan 2009 08:00:00 GMThttp://www.prweb.com/releases/2009/01/prweb1905804.htm Determining Valuations in Challenging Times http://www.prweb.com/releases/2008/11/prweb1569194.htm In today's financial climate, the survival of smaller companies is often dependent on their ability to do deals successfully with larger pharmaceutical companies. The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector, the latest report from PharmaVentures, provides expert guidance on critical aspects of deal-making, including valuations and royalty rate calculations. (PRWeb Nov 5, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1569194.htm

]]> Wed, 05 Nov 2008 08:00:00 GMThttp://www.prweb.com/releases/2008/11/prweb1569194.htm PharmaVentures and Growthink Research Join Forces to Deliver Bioscience Industry Information Solutions http://www.prweb.com/releases/2008/05/prweb955604.htm PharmaVentures has announced its agreement with Growthink Research, the US-based market research company, to distribute the Growthink Research Venture Capital database to PharmaVentures' customers worldwide. (PRWeb May 21, 2008)

Read the full story at http://www.prweb.com/releases/2008/05/prweb955604.htm

]]> Wed, 21 May 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/05/prweb955604.htm PharmaVentures Acted As Advisor For Sale of PhotoBioChem, N.V. Patent Assets to SpectraCure, AB http://www.prweb.com/releases/2008/04/prweb831934.htm PharmaVentures announced today that it had acted as an advisor and broker to the PhotoBioChem, N.V. Holland for the sale of its patent assets to SpectraCure AB, Sweden. (PRWeb Apr 22, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb831934.htm

]]> Tue, 22 Apr 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/04/prweb831934.htm Major New Report Highlights Growing Importance of IP Strategies and Competition Law in the Pharmaceuticals Industry http://www.prweb.com/releases/2008/04/prweb861474.htm PharmaVentures announced today the publication of the report 'Competition Law and Intellectual Property Strategy in the Pharmaceuticals Sector', written by Richard Eccles and Gerry Kamstra, partners in the leading international law firm, Bird & Bird, in London. (PRWeb Apr 17, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb861474.htm

]]> Thu, 17 Apr 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/04/prweb861474.htm PharmaVentures Acted as Advisor for Sale of Dowpharma Small Molecules Business to Dr Reddy’s Laboratories http://www.prweb.com/releases/2008/04/prweb831844.htm PharmaVentures announced today that it acted as advisor to the Dow Chemical Company for the sale of Dowpharma Small Molecules business to Dr. Reddy’s Laboratories. (PRWeb Apr 4, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb831844.htm

]]> Fri, 04 Apr 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/04/prweb831844.htm Anne Vindenes Allen Joins PharmaVentures Ltd to Head Publishing Operations http://www.prweb.com/releases/2008/03/prweb790294.htm PharmaVentures announced today the appointment of Anne Vindenes Allen MSc as Chief Operating Officer of PharmaDeals, the new publishing division of PharmaVentures Ltd. (PRWeb Mar 20, 2008)

Read the full story at http://www.prweb.com/releases/2008/03/prweb790294.htm

]]> Thu, 20 Mar 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/03/prweb790294.htm